Global Regenerative Medicine Market Worth USD 30,237 Million by 2022 - Analysis, Technologies & Forecasts Report 2014-2022 - Key Vendors: Stryker Corp, Zimmer Biomet Holdings, Medtronic - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Regenerative Medicine Market by technology, Material and Application - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022" report to their offering.

The world regenerative medicine market is expected to reach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022. These materials are further subcategorized into different segments. The biologically derived materials accounted for about 4/7th of total market share in 2015, and is estimated to retain its position during the analysis period.

The increasing demand for genetically engineered materials specially due to their unique properties such as promotion of increased proliferation, cellular interactions, and differentiation of cells that facilitates self-assembly into organized structures, and controlling the manipulation of cellular behavior.

Key Benefits:

  • The report includes an extensive analysis of the factors driving as well as restraining the world regenerative medicine market.
  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022 that is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product, material, application, and geography helps in understanding the various types of devices used for different chronic abnormalities.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

Companies Mentioned:

  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Medtronic plc
  • Baxter International Inc.
  • DePuy Synthes
  • Organogenesis Inc. (Advanced Biohealing)
  • Integra Lifesciences Holdings Corporation
  • Acelity Holdings
  • Ocata Therapeutics Inc. (Astellas Pharma Inc.)
  • CryoLife Inc.

Report Structure:

Chapter: 1 INTRODUCTION

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 MARKET OVERVIEW

Chapter: 4 WORLD REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022

Chapter: 5 WORLD REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2015-2022

Chapter: 6 WORLD REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2015-2022

Chapter: 7 WORLD REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY, 2015-2022

Chapter: 8 COMPANY PROFILES

For more information about this report visit http://www.researchandmarkets.com/research/645zj5/regenerative

Related Topics: Biopharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716